Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery

被引:4
|
作者
Singh, Vijai [1 ]
Somvanshi, Pallavi [1 ]
机构
[1] Bioinformat Ctr, Lucknow, Uttar Pradesh, India
关键词
Mycobacterium tuberculosis; Peptide deformylase; Docking; Phylogeny; Drugs;
D O I
10.2174/157018009789108286
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [31] Targeting the Histidine Pathway in Mycobacterium tuberculosis
    Lunardi, Juleane
    Nunes, Jose Eduardo S.
    Bizarro, Cristiano V.
    Basso, Luiz Augusto
    Santos, Diogenes Santiago
    Machado, Pablo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (22) : 2866 - 2884
  • [32] Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery
    Lou, Zhiyong
    Zhang, Xiaoxue
    PROTEIN & CELL, 2010, 1 (05) : 435 - 442
  • [33] Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis
    Berida, Tomayo
    Mckee, Samuel R.
    Chatterjee, Shamba
    Manning, Destinee L.
    Li, Wei
    Pandey, Pankaj
    Tripathi, Siddharth Kaushal
    Mreyoud, Yassin
    Smirnov, Asya
    Doerksen, Robert J.
    Jackson, Mary
    Ducho, Christian
    Stallings, Christina L.
    Roy, Sudeshna
    ACS INFECTIOUS DISEASES, 2023, 9 (11): : 2282 - 2298
  • [34] Cheminformatics-enhanced discovery of therapeutic agents targeting isocitrate lyase in Mycobacterium tuberculosis infections
    Alam, Aftab
    Alqarni, Mohammed H.
    Alotaibi, Bader S.
    Khan, Farhan R.
    Alam, Md. Shamsher
    Aba Alkhayl, Faris F.
    Alhafi, Ali A.
    Almutairi, Turki M.
    Alharbi, Zeyad M.
    Alshehri, Faez Falah
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [35] Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
    Park, Yumi
    Pacitto, Angela
    Bayliss, Tracy
    Cleghorn, Laura A. T.
    Wang, Zhe
    Hartman, Travis
    Arora, Kriti
    Ioerger, Thomas R.
    Sacchettini, Jim
    Rizzi, Menico
    Donini, Stefano
    Blundell, Tom L.
    Ascher, David B.
    Rhee, Kyu
    Breda, Ardala
    Zhou, Nian
    Dartois, Veronique
    Jonnala, Surendranadha Reddy
    Via, Laura E.
    Mizrahi, Valerie
    Epemolu, Ola
    Stojanovski, Laste
    Simeons, Fred
    Osuna-Cabello, Maria
    Ellis, Lucy
    MacKenzie, Claire J.
    Smith, Alasdair R. C.
    Davis, Susan H.
    Murugesan, Dinakaran
    Buchanan, Kirsteen I.
    Turner, Penelope A.
    Huggett, Margaret
    Zuccotto, Fabio
    Jose Rebollo-Lopez, Maria
    Jose Lafuente-Monasterio, Maria
    Sanz, Olalla
    Santos Diaz, Gracia
    Lelievre, Joel
    Ballell, Lluis
    Selenski, Carolyn
    Axtman, Matthew
    Ghidelli-Disse, Sonja
    Pflaumer, Hannah
    Boesche, Markus
    Drewes, Gerard
    Freiberg, Gail M.
    Kurnick, Matthew D.
    Srikumaran, Myron
    Kempf, Dale J.
    Green, Simon R.
    ACS INFECTIOUS DISEASES, 2017, 3 (01): : 18 - 33
  • [36] Mechanisms of a Mycobacterium tuberculosis Active Peptide
    Rao, Komal Umashankar
    Li, Ping
    Welinder, Charlotte
    Tenland, Erik
    Gourdon, Pontus
    Sturegard, Erik
    Ho, James C. S.
    Godaly, Gabriela
    PHARMACEUTICS, 2023, 15 (02)
  • [37] Recent advances in drug discovery against Mycobacterium tuberculosis: Metal-based complexes
    Scarim, Caue Benito
    de Farias, Renan Lira
    de Godoy Netto, Adelino Vieira
    Chin, Chung Man
    dos Santos, Jean Leandro
    Pavan, Fernando Rogerio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214
  • [38] Informatics resources for tuberculosis - Towards drug discovery
    Sundaramurthi, Jagadish Chandrabose
    Brindha, S.
    Reddy, T. B. K.
    Hanna, Luke Elizabeth
    TUBERCULOSIS, 2012, 92 (02) : 133 - 138
  • [39] Peptide Deformylase (def) is essential in Mycobacterium smegmatis, but the essentiality is compensated by inactivation of methionine formylation
    Noga Naor
    Omer Gadot
    Michal Meir
    Daniel Barkan
    BMC Microbiology, 19
  • [40] Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach
    Ejalonibu, Murtala A.
    Ogundare, Segun A.
    Elrashedy, Ahmed A.
    Ejalonibu, Morufat A.
    Lawal, Monsurat M.
    Mhlongo, Ndumiso N.
    Kumalo, Hezekiel M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)